loading
Telomir Pharmaceuticals Inc stock is traded at $1.6399, with a volume of 323.46K. It is up +4.14% in the last 24 hours and up +6.86% over the past month. Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
See More
Previous Close:
$1.57
Open:
$1.58
24h Volume:
323.46K
Relative Volume:
0.07
Market Cap:
$52.78M
Revenue:
-
Net Income/Loss:
$-16.14M
P/E Ratio:
-3.0369
EPS:
-0.54
Net Cash Flow:
$-3.99M
1W Performance:
+2.19%
1M Performance:
+6.86%
6M Performance:
-34.07%
1Y Performance:
-65.21%
1-Day Range:
Value
$1.575
$1.64
1-Week Range:
Value
$1.52
$1.75
52-Week Range:
Value
$1.12
$7.0791

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name
Name
Telomir Pharmaceuticals Inc
Name
Phone
786-396-6723
Name
Address
100 SE 2ND ST, MIAMI
Name
Employee
5
Name
Twitter
Name
Next Earnings Date
2025-09-03
Name
Latest SEC Filings
Name
TELO's Discussions on Twitter

Compare TELO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TELO
Telomir Pharmaceuticals Inc
1.635 53.11M 0 -16.14M -3.99M -0.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
419.42 106.87B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
493.38 63.14B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.77 61.27B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
853.07 51.94B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
167.43 35.04B 398.11M -1.03B -868.57M -5.7032

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-21-25 Initiated Rodman & Renshaw Buy

Telomir Pharmaceuticals Inc Stock (TELO) Latest News

pulisher
10:49 AM

Momentum divergence signals in Telomir Pharmaceuticals Inc. chartQuarterly Profit Review & Target Return Focused Stock Picks - newser.com

10:49 AM
pulisher
06:30 AM

Telomir Pharmaceuticals Inc. stock chart pattern explainedOptions Play & Step-by-Step Trade Execution Guides - newser.com

06:30 AM
pulisher
05:21 AM

Does Telomir Pharmaceuticals Inc. show high probability of rebound2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com

05:21 AM
pulisher
02:32 AM

Combining price and volume data for Telomir Pharmaceuticals Inc.Weekly Loss Report & High Return Stock Watch Alerts - newser.com

02:32 AM
pulisher
Oct 19, 2025

Why Telomir Pharmaceuticals Inc. is moving todayEarnings Beat & Weekly High Conviction Trade Ideas - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

How moving averages guide Telomir Pharmaceuticals Inc. tradingIPO Watch & Free Fast Gain Swing Trade Alerts - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Bearish Setup: Can Acurx Pharmaceuticals Inc. stock withstand economic slowdown2025 Big Picture & Expert Curated Trade Setup Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025
pulisher
Oct 18, 2025

Chart Watch: Will Telomir Pharmaceuticals Inc. stock benefit from AI adoptionJuly 2025 PostEarnings & Stepwise Trade Signal Guides - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

What dividend safety score for Telomir Pharmaceuticals Inc. stockQuarterly Profit Review & Reliable Volume Spike Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025
pulisher
Oct 17, 2025

Is Telomir Pharmaceuticals Inc. stock a buy on dips2025 Winners & Losers & Long-Term Growth Portfolio Plans - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Will Telomir Pharmaceuticals Inc. stock maintain momentum in 2025Gap Down & Real-Time Chart Pattern Alerts - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

FOMO Trade: Will Telomir Pharmaceuticals Inc. stock benefit from AI adoption2025 Key Lessons & Expert-Curated Trade Recommendations - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Can Telomir Pharmaceuticals Inc. stock withstand economic slowdownQuarterly Profit Report & Real-Time Volume Spike Alerts - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Swing Trade: Is Telomir Pharmaceuticals Inc. stock cheap at current valuationPortfolio Performance Summary & Low Risk High Reward Ideas - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Is Telomir Pharmaceuticals Inc. stock trading at a premium valuationJuly 2025 Highlights & Weekly High Return Forecasts - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Telomir Pharmaceuticals Skyrockets 150% on Breakthrough Preclinical Cancer Results - MSN

Oct 17, 2025
pulisher
Oct 17, 2025

Tools to assess Telomir Pharmaceuticals Inc.’s risk profilePortfolio Value Report & Daily Stock Momentum Reports - newser.com

Oct 17, 2025
pulisher
Oct 15, 2025

What to do if you’re stuck in Telomir Pharmaceuticals Inc.2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Telomir Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

How Telomir Pharmaceuticals Inc. stock performs in high volatility marketsQuarterly Portfolio Review & Precise Trade Entry Recommendations - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Custom watchlist performance reports with Telomir Pharmaceuticals Inc.July 2025 Trade Ideas & Capital Efficient Trading Techniques - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer - Palm Beach Daily News

Oct 14, 2025
pulisher
Oct 14, 2025

Telomir-1 shows efficacy against pancreatic cancer cells in lab study - Investing.com Canada

Oct 14, 2025
pulisher
Oct 14, 2025

Telomir Pharmaceuticals, Inc. Announces New Laboratory Findings Demonstrating That Telomir-1 Reduced the Survival of Aggressive Human Pancreatic Cancer Cells in Vitro - MarketScreener

Oct 14, 2025
pulisher
Oct 14, 2025

Telomir-1 shows efficacy against pancreatic cancer cells in lab study By Investing.com - Investing.com South Africa

Oct 14, 2025
pulisher
Oct 14, 2025

Telomir Pharmaceuticals reports new preclinical data on pancreatic cancer By Investing.com - Investing.com South Africa

Oct 14, 2025
pulisher
Oct 14, 2025

Telomir Pharmaceuticals Unveils Promising Pancreatic Cancer Findings - TipRanks

Oct 14, 2025
pulisher
Oct 14, 2025

Kills aggressive pancreatic cancer cells — Telomir‑1 reduces PANC‑1 survival; partial reversal with iron in preclinical study - Stock Titan

Oct 14, 2025
pulisher
Oct 14, 2025

Telomir Pharmaceuticals reports new preclinical data on pancreatic cancer - Investing.com

Oct 14, 2025
pulisher
Oct 14, 2025

Telomir Pharmaceuticals Announces New Data on Telomir-1's Impact on Pancreatic Cancer - TradingView

Oct 14, 2025
pulisher
Oct 14, 2025

Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade

Oct 14, 2025

Telomir Pharmaceuticals Inc Stock (TELO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.29
price down icon 1.96%
$87.11
price down icon 0.50%
$30.59
price down icon 7.75%
$107.88
price up icon 2.61%
biotechnology ONC
$318.50
price up icon 0.66%
$167.51
price up icon 0.84%
Cap:     |  Volume (24h):